Search Results - "Jacobs, Iris" :: K.UTB vyhledávací portál | TBU Library Retrieval Portal

Long-acting recombinant coagulation factor IX albumin fusion protein (rIX-FP) in hemophilia B: results of a phase 3 trial

Long-acting recombinant coagulation factor IX albumin fusion protein (rIX-FP) in hemophilia B: results of a phase 3 trial

by Santagostino, Elena, Martinowitz, Uri, Lissitchkov, Toshko, Pan-Petesch, Brigitte, Hanabusa, Hideji, Oldenburg, Johannes, Boggio, Lisa, Negrier, Claude, Pabinger, Ingrid, von Depka Prondzinski, Mario, Altisent, Carmen, Castaman, Giancarlo, Yamamoto, Koji, Álvarez-Roman, Maria-Teresa, Voigt, Christine, Blackman, Nicole, Jacobs, Iris
Published in Blood (07.04.2016)

Get full text

Journal Article

Efficacy, pharmacokinetics, and safety of subcutaneous C1-esterase inhibitor as prophylaxis in Japanese patients with hereditary angioedema: Results of a Phase 3 study

Efficacy, pharmacokinetics, and safety of subcutaneous C1-esterase inhibitor as prophylaxis in Japanese patients with hereditary angioedema: Results of a Phase 3 study

by Fukuda, Tomoo, Yamagami, Keiko, Kawahata, Kimito, Suzuki, Yuzo, Sasaki, Yoshihiro, Miyagi, Takashi, Jacobs, Iris, Lawo, John-Philip, Glassman, Fiona, Akama, Hideto, Hide, Michihiro, Ohsawa, Isao
Published in Allergology international (01.07.2023)

Get full text

Journal Article

Safety and pharmacokinetics of a novel recombinant fusion protein linking coagulation factor IX with albumin (rIX-FP) in hemophilia B patients

Safety and pharmacokinetics of a novel recombinant fusion protein linking coagulation factor IX with albumin (rIX-FP) in hemophilia B patients

by Santagostino, Elena, Negrier, Claude, Klamroth, Robert, Tiede, Andreas, Pabinger-Fasching, Ingrid, Voigt, Christine, Jacobs, Iris, Morfini, Massimo
Published in Blood (20.09.2012)

Get full text

Journal Article

Prophylactic use of an anti-activated factor XII monoclonal antibody, garadacimab, for patients with C1-esterase inhibitor-deficient hereditary angioedema: a randomised, double-blind, placebo-controlled, phase 2 trial

Prophylactic use of an anti-activated factor XII monoclonal antibody, garadacimab, for patients with C1-esterase inhibitor-deficient hereditary angioedema: a randomised, double-blind, placebo-controlled, phase 2 trial

by Craig, Timothy, Magerl, Markus, Levy, Donald S, Reshef, Avner, Lumry, William R, Martinez-Saguer, Inmaculada, Jacobs, Joshua S, Yang, William H, Ritchie, Bruce, Aygören-Pürsün, Emel, Keith, Paul K, Busse, Paula, Feuersenger, Henrike, Pawaskar, Dipti, Jacobs, Iris, Pragst, Ingo, Doyle, Mittie K
Published in The Lancet (British edition) (05.03.2022)

Get full text

Journal Article

Population Pharmacokinetic/Pharmacodynamic Analysis Of Garadacimab, In Patients With Hereditary Angioedema

Population Pharmacokinetic/Pharmacodynamic Analysis Of Garadacimab, In Patients With Hereditary Angioedema

by Glassman, Fiona, Sharma, Ankur, Cheng, Shen, Johnston, Curtis, De Miguel Lillo, Bernardo, Lawo, John-Philip, Jacobs, Iris, Polhamus, Daniel, Nandy, Partha
Published in Journal of allergy and clinical immunology (01.02.2024)

Get full text

Journal Article

A Phase 1, Randomized, Open-label, Parallel-group Study Comparing Pharmacokinetic Properties Of Garadacimab Administered By Subcutaneous Pre-filled Syringe Assembled To Autoinjector/Pre-filled Pen Versus Pre-filled Syringe Assembled To Needle Safety Device In Healthy Adults

A Phase 1, Randomized, Open-label, Parallel-group Study Comparing Pharmacokinetic Properties Of Garadacimab Administered By Subcutaneous Pre-filled Syringe Assembled To Autoinjector/Pre-filled Pen Versus Pre-filled Syringe Assembled To Needle Safety Device In Healthy Adults

by Glassman, Fiona, Lawo, John-Philip, Bica, Alex, Roberts, Anthony, Kormann, David, Miethke, Soeren, Dziadowiec, Iwona, Caltabiano, Stephen, Jacobs, Iris, Puchalski, Thomas
Published in Journal of allergy and clinical immunology (01.02.2024)

Get full text

Journal Article

Integrated Safety And Efficacy Of Garadacimab For Hereditary Angioedema Prophylaxis Across 3 Clinical Trials: Phase 2, Pivotal Phase 3, And Open-Label Extension Studies

Integrated Safety And Efficacy Of Garadacimab For Hereditary Angioedema Prophylaxis Across 3 Clinical Trials: Phase 2, Pivotal Phase 3, And Open-Label Extension Studies

by Craig, Timothy, Anderson, John, Jacobs, Joshua, Tachdjian, Raffi, Farkas, Henriette, Yang, William, Ohsawa, Isao, Pollen, Maressa, Lawo, John-Philip, Bica, Alex, Jacobs, Iris, Magerl, Markus
Published in Journal of allergy and clinical immunology (01.02.2024)

Get full text

Journal Article

Efficacy and safety of garadacimab, a factor XIIa inhibitor for hereditary angioedema prevention (VANGUARD): a global, multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

Efficacy and safety of garadacimab, a factor XIIa inhibitor for hereditary angioedema prevention (VANGUARD): a global, multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

by Craig, Timothy J, Reshef, Avner, Li, H Henry, Jacobs, Joshua S, Bernstein, Jonathan A, Farkas, Henriette, Yang, William H, Stroes, Erik S G, Ohsawa, Isao, Tachdjian, Raffi, Manning, Michael E, Lumry, William R, Saguer, Inmaculada Martinez, Aygören-Pürsün, Emel, Ritchie, Bruce, Sussman, Gordon L, Anderson, John, Kawahata, Kimito, Suzuki, Yusuke, Staubach, Petra, Treudler, Regina, Feuersenger, Henrike, Glassman, Fiona, Jacobs, Iris, Magerl, Markus
Published in The Lancet (British edition) (01.04.2023)

Get full text

Journal Article

9 - Response to Subcutaneous C1-Esterase Inhibitor (C1-INH [SC]), a Prophylactic Treatment for Adolescents and Adults with Hereditary Angioedema: Results From the Phase 3 COMPACT Trial

9 - Response to Subcutaneous C1-Esterase Inhibitor (C1-INH [SC]), a Prophylactic Treatment for Adolescents and Adults with Hereditary Angioedema: Results From the Phase 3 COMPACT Trial

by Gower, Richard, Li, H. Henry, Levy, Donald Sheldon, Jacobs, Iris
Published in Journal of adolescent health (01.02.2018)

Get full text

Journal Article

Response to Subcutaneous C1-Esterase Inhibitor (C1-INH [SC]), a Prophylactic Treatment for Adolescents and Adults with Hereditary Angioedema: Results From the Phase 3 COMPACT Trial

Response to Subcutaneous C1-Esterase Inhibitor (C1-INH [SC]), a Prophylactic Treatment for Adolescents and Adults with Hereditary Angioedema: Results From the Phase 3 COMPACT Trial

by Gower, Richard, Li, H. Henry, Levy, Donald Sheldon, Jacobs, Iris
Published in Journal of adolescent health (01.02.2018)

Get full text

Journal Article

Pharmacokinetic Profile of Subcutaneous C1-Esterase Inhibitor (C1-INH [SC]) in Adolescent and Adult Patients with Hereditary Angioedema (HAE)

by Pawaskar, Dipti K., Jacobs, Iris, Pragst, Ingo, Feuersenger, Henrike
Published in Journal of allergy and clinical immunology (01.02.2018)

Get full text

Journal Article

Long-acting recombinant fusion protein linking coagulation factor IX with albumin (rIX-FP) in children. Results of a phase 3 trial

Long-acting recombinant fusion protein linking coagulation factor IX with albumin (rIX-FP) in children. Results of a phase 3 trial

by Kenet, Gili, Chambost, Hervé, Male, Christoph, Lambert, Thierry, Halimeh, Susan, Chernova, Tatiana, Mancuso, Maria Elisa, Curtin, Julie, Voigt, Christine, Li, Yanyan, Jacobs, Iris, Santagostino, Elena
Published in Thrombosis and haemostasis (01.10.2016)

Get more information

Journal Article

Efficacy and Safety of Subcutaneous Garadacimab for the Prophylaxis of Hereditary Angioedema Attacks in Adults and Adolescent Patients with HAE: Results from a Multicenter, Placebo-Controlled Phase 3 Trial

Efficacy and Safety of Subcutaneous Garadacimab for the Prophylaxis of Hereditary Angioedema Attacks in Adults and Adolescent Patients with HAE: Results from a Multicenter, Placebo-Controlled Phase 3 Trial

by Craig, Timothy, Magerl, Markus, Reshef, Avner, Li, Huamin, Jacobs, Joshua, Bernstein, Jonathan, Farkas, Henriette, Yang, William, Stroes, Erik, Ohsawa, Isao, Tachdjian, Raffi, Manning, Michael, Lumry, William, Saguer, Inmaculada Martinez, Aygören-Pürsün, Emel, Ritchie, Bruce, Sussman, Gordon, Anderson, John, Kawahata, Kimito, Suzuki, Yusuke, Staubach, Petra, Treudler, Regina, Feuersenger, Henrike, Wieman, Lolis, Jacobs, Iris
Published in Journal of allergy and clinical immunology (01.02.2023)

Get full text

Journal Article

Bleeding Risk Reduction in Relation to Predicted Factor IX Levels in Hemophilia B Patients Receiving Idelvion (rIX-FP)

Bleeding Risk Reduction in Relation to Predicted Factor IX Levels in Hemophilia B Patients Receiving Idelvion (rIX-FP)

by Roberts, John, Fosser, Cecilia, Tortorici, Michael, Veldman, Alex, Jacobs, Iris C., Sidhu, Jagdev
Published in Blood (02.12.2016)

Get full text

Journal Article

Long-term safety and efficacy of subcutaneous C1-inhibitor in older patients with hereditary angioedema

Long-term safety and efficacy of subcutaneous C1-inhibitor in older patients with hereditary angioedema

by Bernstein, Jonathan A., Schwartz, Lawrence, Yang, William, Baker, James, Anderson, John, Farkas, Henriette, Aygören-Pürsün, Emel, Bygum, Anette, Jacobs, Iris, Feuersenger, Henrike, Pragst, Ingo, Riedl, Marc A.
Published in Annals of allergy, asthma, & immunology (01.09.2020)

Get full text

Journal Article

Long-Term Outcomes with Subcutaneous C1-Inhibitor Replacement Therapy for Prevention of Hereditary Angioedema Attacks

Long-Term Outcomes with Subcutaneous C1-Inhibitor Replacement Therapy for Prevention of Hereditary Angioedema Attacks

by Craig, Timothy, Zuraw, Bruce, Longhurst, Hilary, Cicardi, Marco, Bork, Konrad, Grattan, Clive, Katelaris, Constance, Sussman, Gordon, Keith, Paul K, Yang, William, Hébert, Jacques, Hanzlikova, Jana, Staubach-Renz, Petra, Martinez-Saguer, Inmaculada, Magerl, Markus, Aygören-Pürsün, Emel, Farkas, Henriette, Reshef, Avner, Kivity, Shmuel, Neri, Sergio, Crisan, Ioana, Caballero, Teresa, Baeza, Maria L, Hernandez, Maria Dolores, Li, Henry, Lumry, William, Bernstein, Jonathan A, Hussain, Iftikar, Anderson, John, Schwartz, Lawrence B, Jacobs, Joshua, Manning, Michael, Levy, Donald, Riedl, Marc, Christiansen, Sandra, Feuersenger, Henrike, Pragst, Ingo, Mycroft, Sarah, Pawaskar, Dipti, Jacobs, Iris
Published in The journal of allergy and clinical immunology in practice (Cambridge, MA) (01.07.2019)

Get more information

Journal Article

Subcutaneous C1-esterase inhibitor to prevent hereditary angioedema attacks: Safety findings from the COMPACT trial

Subcutaneous C1-esterase inhibitor to prevent hereditary angioedema attacks: Safety findings from the COMPACT trial

by Li, H Henry, Mycroft, Sarah, Christiansen, Sandra, Wood, Daniel N, Feuersenger, Henrike, Pawaskar, Dipti, Jacobs, Iris
Published in Allergy and asthma proceedings (14.09.2018)

Get more information

Journal Article

Efficacy and Safety Results of Prolong-9FP Clinical Program of Recombinant Fusion Protein Linking Coagulation Factor IX with Albumin (rIX-FP) in Previously Treated Patients with Hemophilia B

Efficacy and Safety Results of Prolong-9FP Clinical Program of Recombinant Fusion Protein Linking Coagulation Factor IX with Albumin (rIX-FP) in Previously Treated Patients with Hemophilia B

by Santagostino, Elena, Voigt, Christine, Wolko, Denise, Cole, Grace, Li, Yanyan, Jacobs, Iris C.
Published in Blood (03.12.2015)

Get full text

Journal Article

Long-Term Use of Coagulation Factor IX (Recombinant) Albumin Fusion Protein (rIX-FP) in Previously Treated Patients with Hemophilia B in the Prolong-9FP Program

Long-Term Use of Coagulation Factor IX (Recombinant) Albumin Fusion Protein (rIX-FP) in Previously Treated Patients with Hemophilia B in the Prolong-9FP Program

by Lubetsky, Aaron, Martinowitz, Uri, Lissitchkov, Toshko, Voigt, Christine, Wolko, Denise, Jacobs, Iris C., Santagostino, Elena
Published in Blood (03.12.2015)

Get full text

Journal Article

Prevention of Attacks of Hereditary Angioedema (HAE) with Subcutaneous C1-Esterase Inhibitor (C1-INH [SC]) by Anatomical Location: Results From the Phase III COMPACT Study (NCT01912456)

Prevention of Attacks of Hereditary Angioedema (HAE) with Subcutaneous C1-Esterase Inhibitor (C1-INH [SC]) by Anatomical Location: Results From the Phase III COMPACT Study (NCT01912456)

by Levy, Donald S., Chiao, Joseph, Feuersenger, Henrike, Craig, Timothy, Longhurst, Hilary J., Cicardi, Marco, Zuraw, Bruce L., Jacobs, Iris
Published in Journal of allergy and clinical immunology (01.02.2018)

Get full text

Journal Article